Market Overview

Genpact, AstraZeneca Extend Finance and Accounting Services Agreement

Related G
5 Stocks to Lose Post-Earnings - Analyst Blog
Coverage Initiated on Accenture - Analyst Blog

Genpact Limited (NYSE: G) today announced a multi-year contract extension for its global finance and accounting (F&A) services agreement with leading pharmaceutical company AstraZeneca (NYSE: AZN)

The AstraZeneca-Genpact relationship launched in 2009. Through its unique Smart Enterprise Processes (SEPSM) methodology for improving the effectiveness of business processes, combined with analytical insights, technology, and global delivery excellence, Genpact has helped AstraZeneca achieve impact through continuous process improvement initiatives and increased global compliance through the standardization and harmonization of finance processes.

The multi-year contract extension encompasses transactional finance operations covering procure-to-pay (P2P), travel and expense (T&E), record-to-report (R2R), sales order-to-cash (SOTC), data management services and support for AstraZeneca's Global Transactional Finance transformation program – delivered from five delivery centers globally. 

In addition, AstraZeneca has been engaged with Genpact's IT business to deploy a global Travel and Expense platform and more recently began a three-year engagement with Genpact's Akritiv OTCbusiness process as a service (BPaaS) platform to implement the solution globally in an effort to drive working capital improvement.  The Akritiv BPaaS platform will leverage AstraZeneca's existing ERP investments to accelerate cash conversions, compress dispute resolution cycle time,

See full press release

Posted-In: News Guidance Contracts Management Global

 

Most Popular

Related Articles (AZN + G)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free